Address

TPG Biotechnology Partners LP
United States

Open Map


VCID: 7658
    Profile

    Corporate information

    Official name
    TPG Biotechnology Partners, L.P.

    Registration country
    Investment activity status
    Active investor

    Fund terms

    Fund manager
    Vintage
    2002
    Fund type

    Funding rounds

    (31 Dec 2002)

    Profile Country Notes
    California Public Employees' Retirement System Agency in the California executive branch that manages pension and health benefits for the California public employees, retirees, and their families. United States

    Current and past shareholders

    Investor Contacts Round
    California Public Employees' Retirement System logo California Public Employees' Retirement System
    Agency in the California executive branch that manages pension and health benefits for the California public employees, retirees, and their families.
    +1 (916) 795-3829
    Fund Closing

    Selected investments

    Country Date Notes
    Nutrinia Ltd
    Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants.
    Israel 18 Aug 2016 Series D
    Initial investment. Led the investment round. Active
    CardioDx Inc
    United States 1 Aug 2012
    11 May 2011
    Series F
    Initial investment. Round participant. Active
    Elevation Pharmaceuticals Inc
    United States 1 Jan 2012 Series B
    DNAnexus Inc
    Software company providing next generation cloud-based sequence data management solutions, analysis, and visualization.
    United States 12 Oct 2011 Series B
    Active
    Genomatica Inc
    United States 1 Apr 2010 Series C
    Alder Biopharmaceuticals Inc
    Developer of antibody therapeutics.
    United States N/A
    Elevance Renewable Sciences Inc
    United States N/A

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.